You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CTCAE - Common Terminology Criteria for Adverse Events

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of

Not yet recruiting
  • Bladder Cancer
  • +3 more
  • Geriatric-8 Survey
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Tumors Trial in Seoul (ePRO-CTCAE application)

Active, not recruiting
  • Neoplasms
  • ePRO-CTCAE application
  • Seoul, Korea, Republic of
  • +1 more
Jul 3, 2021

PRO-CTCAE for Adult-type Diffuse Gliomas Chinese Population

Not yet recruiting
  • Glioma
  • +3 more
    • Beijing, Beijing, China
    • +16 more
    Aug 4, 2022

    Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority

    Recruiting
    • Prostate Cancer
    • +2 more
    • Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
    • +7 more
    • Quebec, Canada
      CHUdeQuebec
    Apr 7, 2023

    Cancer Trial in Kufstein (Patient-reported outcomes assessment, CTCAE rating, PRO data is displayed)

    Recruiting
    • Cancer
    • Patient-reported outcomes assessment
    • +2 more
    • Kufstein, Austria
      Bezirkskrankenhaus Kufstein
    Apr 5, 2022

    Version of Common Terminology Criteria for Adverse Events Via

    Completed
    • Lymphomas
    • +2 more
      • New York, New York
      • +1 more
      Jul 16, 2020

      Version of the Common Criteria for Adverse Events

      Recruiting
      • Survivorship
      • Cancer
      • Childhood Cancer Survivors (CCSS)
      • +2 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Oct 8, 2021

      Validation of the Italian Version of the PRO-CTCAE

      Recruiting
      • Malignant Neoplasms
      • PRO-CTCAE items
      • Bari, Italy
      • +24 more
      Mar 2, 2021

      Testing a Spanish Version of a Patient Toxicity Questionnaire

      Completed
      • Breast Cancer
      • +4 more
        • Bethesda, Maryland
          National Cancer Institute (NCI), 9000 Rockville Pike
        Dec 13, 2019

        Malignant Tumor Trial (Experimental: DaRT seeds)

        Not yet recruiting
        • Malignant Tumor
        • Experimental: DaRT seeds
        • (no location specified)
        Mar 27, 2023

        Radiation Dermatitis Trial in Miami (StrataXRT, Aquaphor)

        Not yet recruiting
        • Radiation Dermatitis
        • Miami, Florida
          Miami Cancer Institute
        Sep 29, 2022

        Cervical Cancer, Stage IIB Trial (Curcumin, Placebo oral tablet)

        Withdrawn
        • Cervical Cancer, Stage IIB
        • (no location specified)
        Dec 5, 2022

        Alopecia, Chemo-Induced Change, Hair Loss Trial in Tucson (Keratinocyte growth factor)

        Completed
        • Alopecia
        • +3 more
        • Keratinocyte growth factor
        • Tucson, Arizona
          University of Arizona
        Dec 15, 2022

        Cardiovascular Diseases Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))

        Recruiting
        • Cardiovascular Diseases
        • Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
        • Nassau, The Bahamas, Bahamas
          The Partners Clinical Research Centre at The Medical Pavilion
        Oct 17, 2023

        Triple Negative Breast Cancer (TNBC) Trial in United States (Combination of liposomal doxorubicin)

        Not yet recruiting
        • Triple Negative Breast Cancer (TNBC)
        • Combination of liposomal doxorubicin
        • Elizabeth, New Jersey
        • +7 more
        Jul 13, 2023

        Frailty Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))

        Recruiting
        • Frailty
        • Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
        • Nassau, The Bahamas, Bahamas
          The Partners Clinical Research Centre at The Medical Pavilion
        Oct 2, 2023

        Colo-rectal Cancer, Neuropathy;Peripheral, Mucositis Trial in Tanta (Pentoxifylline, Placebo, FOLFOX-6 regimen)

        Enrolling by invitation
        • Colo-rectal Cancer
        • +2 more
        • Tanta, Gharbyia, Egypt
          Tanta University
        Oct 18, 2022

        Aging Frailty Trial in Abu Dhabi (StromaForte)

        Recruiting
        • Aging Frailty
        • StromaForte
        • Abu Dhabi, United Arab Emirates
          Burjeel Medical City
        Oct 2, 2023

        Osteo Arthritis Knee Trial in Abu Dhabi (Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))

        Recruiting
        • Osteo Arthritis Knee
        • Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
        • Abu Dhabi, United Arab Emirates
          Burjeel Medical City
        Oct 11, 2023

        Multiple Myeloma Trial (Continued treatment adapted to the response)

        Completed
        • Multiple Myeloma
        • Continued treatment adapted to the response
        • (no location specified)
        Jan 14, 2023

        Ultra-hypofractionated Radiotherapy in Breast Cancer Patients

        Recruiting
        • Female Breast Cancer
        • ultra-hypofractionated whole breast irradiation
        • Perugia, Italy
          Radiation Oncology Section, Department of Medicine and Surgery,
        Oct 16, 2022

        Breast Cancer, DCIS Trial in Canada (APBI: 30 Gy, APBI: 27.5 Gy)

        Active, not recruiting
        • Breast Cancer
        • DCIS
        • APBI: 30 Gy
        • APBI: 27.5 Gy
        • Barrie, Ontario, Canada
        • +9 more
        Apr 4, 2022

        Breast Cancer Trial in United States (Eribulin Mesylate, Ixabepilone)

        Completed
        Has Results
        • Breast Cancer
        • Sedona, Arizona
        • +49 more
        Nov 2, 2021

        Thrombocytopenia Trial (Hetrombopag)

        Not yet recruiting
        • Thrombocytopenia
        • (no location specified)
        Sep 7, 2023

        Cancer Trial in Rotterdam (Dexamethasone, H1 Antihistaminics)

        Not yet recruiting
        • Cancer
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus MC
        Nov 1, 2023